**Question:** True about Imipramine is: September 2007

A. It is a selective serotonin reuptake inhibitor (SSRI).
B. It is a beta-blocker.
C. It is a calcium channel blocker.
D. It is a benzodiazepine.

**Core Concept:**
Imipramine is a tricyclic antidepressant (TCA) used for the treatment of major depressive disorder, anxiety disorders, and certain sleep disorders. TCAs work by inhibiting the reuptake of neurotransmitters, particularly serotonin and norepinephrine, into the presynaptic neuron, increasing their concentration in the postsynaptic neuron, and promoting their action at the neural synapse.

**Why the Correct Answer is Right:**
Imipramine is classified as a tricyclic antidepressant, not because of its mechanism of action but due to its chemical structure. Unlike selective serotonin reuptake inhibitors (SSRIs), TCAs are not selective for serotonin reuptake inhibition. They have a broader spectrum of action, affecting multiple neurotransmitter systems.

**Why Each Wrong Option is Incorrect:**

A. Selective serotonin reuptake inhibitors (SSRIs) are a different class of antidepressants, and they selectively inhibit serotonin reuptake. Imipramine is not selective for serotonin reuptake inhibition.

B. Beta-blockers (e.g., propranolol) are drugs used for treating hypertension, angina, and heart palpitations. They work by blocking the action of adrenaline and noradrenaline on beta-adrenergic receptors. Imipramine does not belong to this class of drugs.

C. Calcium channel blockers (e.g., verapamil, nifedipine) are medications used for treating hypertension, angina, and Raynaud's phenomenon. They work by inhibiting calcium channels in cardiac and vascular smooth muscle cells, leading to vasodilation and reduced heart rate. Imipramine is not a calcium channel blocker.

D. Benzodiazepines (e.g., diazepam) are a class of drugs used primarily for anxiety disorders, insomnia, and seizures. They work by binding to gamma-aminobutyric acid (GABA) receptors and enhancing their activity, leading to decreased neuronal excitability. Imipramine is not a benzodiazepine.

**Clinical Pearl:**

Imipramine is a tricyclic antidepressant used to treat major depressive disorder, anxiety disorders, and sleep disorders. Its mechanism of action involves blocking the reuptake of norepinephrine, serotonin, and dopamine in the central nervous system, leading to increased neurotransmitter availability at the synaptic cleft and enhanced synaptic transmission. This helps in improving mood, sleep, and reducing anxiety symptoms. Imipramine is not a selective serotonin reuptake inhibitor (SSRI) or a beta-blocker like propranolol or atenolol. Imipramine is not a calcium